Furthermore, a retrospective analysis of patients with progressing PCa despite ADT revealed that PC-SPES has measurable effects on the post-therapy decline in serum prostate-specific antigen (PSA), suggesting that PC-SPES may be an effective treatment for AIPCa, although additional study is needed to identify the active components12, 13. Here, KLK3 is linked to posterior cortical atrophy.